Showing results (2141-2150 of 6,777) with videos related to
Sort By:
Pageof 678
Clinical Therapeutics|May 7, 2017
Influence of Cdx2 and TaqI Gene Variants on Vitamin D3 Modulated Intracellular Chemokine Positive T-Cell Subsets in Pulmonary TuberculosisMurugesan Harishankar, Paramasivam SelvarajClinical Therapeutics|May 10, 2017
Population Pharmacokinetics of Valproic Acid in Patients with Mania: Implication for Individualized Dosing RegimensJanthima MethaneethornClinical Therapeutics|May 2, 2017
Vitamin D Status and the Host Resistance to Infections: What It Is Currently (Not) UnderstoodPierre Olivier Lang, Richard AspinallClinical Therapeutics|May 28, 2018
Canada's Study of Adherence Outcomes in Patients Receiving Adalimumab: 3-year Results From the COMPANION StudyJohn K Marshall, Louis Bessette, Neil H Shear, et al.Clinical Therapeutics|April 4, 2018
Trends in Readmission Rates, Hospital Charges, and Mortality for Patients With Chronic Obstructive Pulmonary Disease (COPD) in Florida From 2009 to 2014Xinyi Jiang, Hong Xiao, Richard Segal, et al.Clinical Therapeutics|April 4, 2018
Progression-free Survival With First-line Endocrine-based Therapies Among Postmenopausal Women With HR+/HER2- Metastatic Breast Cancer:: A Network Meta-analysisRajeev Ayyagari, Derek Tang, Oscar Patterson-Lomba, et al.Clinical Therapeutics|May 5, 2018
A Phase I, Single- and Multiple-dose Study to Evaluate the Pharmacokinetics of Elbasvir and Grazoprevir in Healthy Chinese ParticipantsTommy Tsang Cheung, Joanne Wing Yan Chiu, Man Fung Yuen, et al.Clinical Therapeutics|April 21, 2018
Efficacy and Safety of Fixed-dose Combination Therapy With Telmisartan and Rosuvastatin in Korean Patients With Hypertension and Dyslipidemia: TELSTA-YU (TELmisartan-rosuvaSTAtin from YUhan), a Multicenter, Randomized, 4-arm, Double-blind, Placebo-controlled, Phase III StudyGyu Chul Oh, Jung-Kyu Han, Ki Hoon Han, et al.Clinical Therapeutics|September 27, 2016
Perioperative β-Blockade in Noncardiac Surgery: A Cautionary Tale of Over-reliance on Small Randomized Prospective TrialsJames Durham, William C MackeyClinical Therapeutics|April 28, 2018
Relative Bioavailability of a Single 4-mg Dose of Somatropin Administered by Subcutaneous Injection or by Needle-free Device and Coadministered With the Growth Hormone Inhibitor Octreotide Acetate in Healthy Adult SubjectsDarin B Brimhall, Niclas Petri, Pina D'AngeloPageof 678